5
ABL Bio-Technologies
526955 BSE
ABL Bio-Technologies
Healthcare BSE: 526955 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.04 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of -31.8% over last 3 years.
- Contingent liabilities of Rs.4.52 Cr.
- Company might be capitalizing the interest cost
Growth Rate
Revenue Growth
-100%
Net Income Growth
20% lower than
3Y
Quarterly Results
| Particulars | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0.02 | 0 | 0 | 0 |
| Operating Profit | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | 0 | -0.02 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 |
| PBT | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.03 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS in Rs | -0.04 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 7 | 9.27 | 16.86 | 8.15 | 2.22 | 0.04 | 0 | 0 |
| Expenses | 5.76 | 7.54 | 13.63 | 7.76 | 22.22 | 0.57 | 0.12 | 0.02 |
| Operating Profit | 1.24 | 1.73 | 3.23 | 0.39 | -20 | -0.53 | -0.12 | -0.02 |
| OPM % | 17.71% | 18.66% | 19.16% | 4.79% | -900.9% | -1325% | — | — |
| Other Income | 1.01 | 1.56 | 0.1 | 0 | 0 | 0 | 0.01 | 0 |
| Interest | 0.28 | 0.62 | 1.16 | 1.12 | 0.52 | 0 | 0 | 0 |
| Depreciation | 0.16 | 0.21 | 0.22 | 0.23 | 0.12 | 0.07 | 0.07 | 0.11 |
| PBT | 1.81 | 2.46 | 1.95 | -0.96 | -20.64 | -0.6 | -0.18 | -0.13 |
| Tax % | 7.18% | 12.6% | 9.74% | 1.04% | 0% | 0% | 0% | — |
| Net Profit | 1.68 | 2.15 | 1.76 | -0.97 | -20.64 | -0.6 | -0.18 | -0.12 |
| EPS in Rs | — | — | — | -1.18 | -25.17 | -0.73 | -0.22 | -0.16 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4.1 | 4.1 | 4.1 | 8.2 | 8.2 | 8.2 | 8.2 |
| Reserves | 0.94 | 6.76 | 8.52 | 32.01 | 11.13 | 10.54 | 10.36 |
| Borrowings | 5.17 | 10.13 | 14.14 | 16.59 | 16.66 | 16.96 | 17.1 |
| Other Liabilities | 4.33 | 6.4 | 7.84 | 8.88 | 9.6 | 9.53 | 9.43 |
| Total Liabilities | 14.54 | 27.39 | 34.6 | 65.68 | 45.59 | 45.23 | 45.09 |
| Fixed Assets | 2.67 | 7.38 | 7.59 | 7.42 | 35.1 | 34.86 | 34.79 |
| CWIP | 0 | 5.92 | 7.34 | 7.62 | 0 | 0 | 0 |
| Investments | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.31 |
| Other Assets | 10.57 | 12.79 | 18.37 | 49.34 | 9.19 | 9.07 | 8.99 |
| Total Assets | 14.54 | 27.39 | 34.6 | 65.68 | 45.59 | 45.23 | 45.09 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 |
|---|---|---|---|---|---|---|---|
| Operating | -3.33 | 1.79 | -1.64 | 0.77 | -9.56 | -0.47 | -0.11 |
| Investing | -0.05 | -5.28 | -1.9 | -0.89 | -19.88 | 0.17 | -0.02 |
| Financing | 3.38 | 5.99 | 1.21 | 29.97 | -0.45 | 0.36 | 0.13 |
| Net Cash Flow | 0 | 2.5 | -2.33 | 29.85 | -29.89 | 0.06 | 0 |
| Free Cash Flow | -3.38 | -3.49 | -3.54 | -0.12 | -38.25 | -0.3 | -0.12 |
| CFO/OP | -265 | 103 | -51 | 197 | 48 | 89 | 92 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 160 | 121 | 163 | 321 | 44.39 | 2,920 | — |
| Inventory Days | 188 | 199 | 113 | 252 | 6.53 | 0 | — |
| Days Payable | 478 | 354 | 278 | 706 | 827 | — | — |
| Cash Conversion Cycle | -131 | -34.41 | -1.14 | -134 | -776 | 2,920 | — |
| Working Capital Days | 256 | 142 | 215 | 424 | -159 | -8,943 | — |
| ROCE % | — | 19.81% | 13.24% | 0.41% | -43.37% | -1.67% | -0.5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view ABL Bio-Technologies insights
49 extracted metrics + investor summaries across FY06–FY26.
Documents
1
Announcement Under Reg 30
3 Mar - FMV Global Innovations (wholly-owned) acquired 75% of PT Fischer Pariko Medical Ventures, Indonesia (incorporated 14-10-2024). 3 Mar - FMV Global Innovations (wholly-owned) acquired 75% of PT Fischer Pariko Medical Ventures, Indonesia (incorporated 14-10-2024).
2
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
12 Feb - Monitoring agency: no deviation; Rs.358.46 crore preferential issue; Rs.270.40 crore raised as of Dec 31, 2025. 12 Feb - Monitoring agency: no deviation; Rs.358.46 crore preferential issue; Rs.270.40 crore raised as of Dec 31, 2025.
3
Announcement under Regulation 30 (LODR)-Press Release / Media Release
9 Feb - Time Medical India launched CDSCO‑certified MICA and QUIN 1.5T MRI platforms at IRIA 2026, helium-free and zero boil-off. 9 Feb - Time Medical India launched CDSCO‑certified MICA and QUIN 1.5T MRI platforms at IRIA 2026, helium-free and zero boil-off.
Frequently Asked Questions about ABL Bio-Technologies
What does ABL Bio-Technologies Ltd do?
ABL Bio Technologies Limited is an India-based company. The company is engaged in bio technology industry.
Where is ABL Bio-Technologies Ltd (526955) listed?
ABL Bio-Technologies Ltd trades under code 526955 on the BSE.
Which sector does ABL Bio-Technologies Ltd belong to?
ABL Bio-Technologies Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
Company Information
ABL Bio Technologies Limited is an India-based company. The company is engaged in bio technology industry.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526955.md for ABL Bio-Technologies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.